These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18653939)

  • 1. Rejection of pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) by low pressure reverse osmosis membranes.
    Ozaki H; Ikejima N; Shimizu Y; Fukami K; Taniguchi S; Takanami R; Giri RR; Matsui S
    Water Sci Technol; 2008; 58(1):73-81. PubMed ID: 18653939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of silica fouling on the removal of pharmaceuticals and personal care products by nanofiltration and reverse osmosis membranes.
    Lin YL; Chiou JH; Lee CH
    J Hazard Mater; 2014 Jul; 277():102-9. PubMed ID: 24560524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of endocrine disrupting chemicals (EDCs) using low pressure reverse osmosis membrane (LPROM).
    Razak AR; Ujang Z; Ozaki H
    Water Sci Technol; 2007; 56(8):161-8. PubMed ID: 17978444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rejection of pharmaceutically active compounds and endocrine disrupting compounds by clean and fouled nanofiltration membranes.
    Yangali-Quintanilla V; Sadmani A; McConville M; Kennedy M; Amy G
    Water Res; 2009 May; 43(9):2349-62. PubMed ID: 19303127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection of trace organic compounds by high-pressure membranes.
    Kim TU; Amy G; Drewes JE
    Water Sci Technol; 2005; 51(6-7):335-44. PubMed ID: 16003994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents.
    Esplugas S; Bila DM; Krause LG; Dezotti M
    J Hazard Mater; 2007 Nov; 149(3):631-42. PubMed ID: 17826898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of selected endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) during ferrate(VI) treatment of secondary wastewater effluents.
    Yang B; Ying GG; Zhao JL; Liu S; Zhou LJ; Chen F
    Water Res; 2012 May; 46(7):2194-204. PubMed ID: 22342241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A QSAR model for predicting rejection of emerging contaminants (pharmaceuticals, endocrine disruptors) by nanofiltration membranes.
    Yangali-Quintanilla V; Sadmani A; McConville M; Kennedy M; Amy G
    Water Res; 2010 Jan; 44(2):373-84. PubMed ID: 19616272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.
    Kim SD; Cho J; Kim IS; Vanderford BJ; Snyder SA
    Water Res; 2007 Mar; 41(5):1013-21. PubMed ID: 16934312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rejection of pharmaceuticals by forward osmosis membranes.
    Jin X; Shan J; Wang C; Wei J; Tang CY
    J Hazard Mater; 2012 Aug; 227-228():55-61. PubMed ID: 22640821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A QSAR-like analysis of the adsorption of endocrine disrupting compounds, pharmaceuticals, and personal care products on modified activated carbons.
    Redding AM; Cannon FS; Snyder SA; Vanderford BJ
    Water Res; 2009 Aug; 43(15):3849-61. PubMed ID: 19592065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) in the aquatic environment: implications for the drinking water industry and global environmental health.
    Rahman MF; Yanful EK; Jasim SY
    J Water Health; 2009 Jun; 7(2):224-43. PubMed ID: 19240349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal efficiency of pharmaceuticals and personal care products with varying wastewater treatment processes and operating conditions - conception of a database and first results.
    Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
    Water Sci Technol; 2008; 57(1):49-56. PubMed ID: 18192740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of adsorption capacity for pharmaceuticals, personal care products and endocrine disrupting chemicals onto various adsorbent materials.
    Bunmahotama W; Lin TF; Yang X
    Chemosphere; 2020 Jan; 238():124658. PubMed ID: 31548174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal mechanisms for endocrine disrupting compounds (EDCs) in wastewater treatment - physical means, biodegradation, and chemical advanced oxidation: a review.
    Liu ZH; Kanjo Y; Mizutani S
    Sci Total Environ; 2009 Jan; 407(2):731-48. PubMed ID: 18992918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of membrane bioreactors as decentralised systems for removal of endocrine disrupting chemicals and pharmaceuticals.
    Le-Minh N; Coleman HM; Khan SJ; van Luer Y; Trang TT; Watkins G; Stuetz RM
    Water Sci Technol; 2010; 61(5):1081-8. PubMed ID: 20220228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
    Kimura K; Iwase T; Kita S; Watanabe Y
    Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated pretreatment with capacitive deionization for reverse osmosis reject recovery from water reclamation plant.
    Lee LY; Ng HY; Ong SL; Tao G; Kekre K; Viswanath B; Lay W; Seah H
    Water Res; 2009 Oct; 43(18):4769-77. PubMed ID: 19700181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of toxic ions (chromate, arsenate, and perchlorate) using reverse osmosis, nanofiltration, and ultrafiltration membranes.
    Yoon J; Amy G; Chung J; Sohn J; Yoon Y
    Chemosphere; 2009 Sep; 77(2):228-35. PubMed ID: 19679331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination and occurrence of organic micropollutants in reverse osmosis treatment for advanced water reuse.
    Gomez V; Majamaa K; Pocurull E; Borrull F
    Water Sci Technol; 2012; 66(1):61-71. PubMed ID: 22678201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.